We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon
Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
I know I state the obvious. As long as there have been markets, there have been swindlers. For the 1,000s of years we have markets, the brightest people in the industry have been snookered. There are are some good crooks out there, now, and very sharp people getting it. Down a dollar today, someone made some bucks. I have a lot of this stock, I believe in the science. But I have said before the science is passing IMMU. I am most distressed by the friends and patients, I have lost to the greed and incompetence of our system. Is time to rethink how we do medicine In the US
We are very surprised to have received the complete response letter this afternoon,” Sarepta CEO Dough Ingram said in a statement released by the company. “Over the entire course of its review, the Agency did not raise any issues suggesting the non-approvability of golodirsen, including the issues that formed the basis of the complete response letter.”
I thought the share price would resolve itself in that triangular channel in October on BLA resubmission. Maybe that DS-1062 data release will materially impact the share price today though. We'll find out soon.